Lo Loestrin FE is not discontinued. It is an oral contraceptive approved by the U.S. Food and Drug Administration (FDA) for the prevention of pregnancy [1].
When Does Lo Loestrin FE's Patent Expire?
The original patent for Lo Loestrin FE expired in June 2020 [2]. However, additional patents related to the drug's formulation may still be in effect [3]. Information regarding the specific patent expiry dates for Lo Loestrin FE can be found on DrugPatentWatch.com [2].
Are There Generic Versions of Lo Loestrin FE Available?
Yes, generic versions of Lo Loestrin FE have become available following the expiry of its primary patents [4]. These generics contain the same active ingredients and are intended to provide the same therapeutic effects as the brand-name product.
What is the Difference Between Lo Loestrin FE and Lo Loestrin?
Lo Loestrin FE contains both a progestin (norethindrone acetate) and an estrogen (ethinyl estradiol) along with iron. The iron is included in the inactive pills to supplement iron stores or prevent iron deficiency anemia in women who do not have a menstrual period while using the product [1]. "Lo Loestrin" without the "FE" designation would refer to the same active hormonal components but without the added iron supplement [1].
How Does Lo Loestrin FE Work?
Lo Loestrin FE is a combination birth control pill that works by preventing ovulation, thickening cervical mucus to block sperm, and thinning the lining of the uterus [1].
What are the Risks and Side Effects of Lo Loestrin FE?
Like all hormonal contraceptives, Lo Loestrin FE carries risks and potential side effects. These can include blood clots, stroke, and heart attack, especially in women with risk factors such as smoking or high blood pressure [1]. Other common side effects may include nausea, headache, breast tenderness, and irregular bleeding [1]. It is important for individuals to discuss their medical history and any concerns with a healthcare provider before starting this medication [1].